Ngene Therapeutics Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 2

Ngene Therapeutics General Information

Description

Manufacturer of gene-based stem cell therapy products designed for acute alcoholic hepatitis and various neuroinflammatory indications. The company develops optimized, safe, and homogenous stem cells by combining CRISPR/Cas9 technology with cell lines produced by the global stem cell ArrayTM.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • MD
  • United States
Primary Industry
Biotechnology
Corporate Office
  • MD
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ngene Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ngene Therapeutics‘s full profile, request access.

Request a free trial

Ngene Therapeutics FAQs

  • Where is Ngene Therapeutics headquartered?

    Ngene Therapeutics is headquartered in MD.

  • What industry is Ngene Therapeutics in?

    Ngene Therapeutics’s primary industry is Biotechnology.

  • Is Ngene Therapeutics a private or public company?

    Ngene Therapeutics is a Private company.

  • What is Ngene Therapeutics’s current revenue?

    The current revenue for Ngene Therapeutics is .

  • When was Ngene Therapeutics acquired?

    Ngene Therapeutics was acquired on 18-Dec-2020.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process